Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1980-10-23, 1980-11-13
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1980

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
yes
Remarks:
10 h light instead of 12. 2 doses only.
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)
EC Number:
229-722-6
EC Name:
Pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)
Cas Number:
6683-19-8
Molecular formula:
C73H108O12
IUPAC Name:
3-{[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl]oxy}-2,2-bis({[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoyl]oxy}methyl)propyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate
Details on test material:
- Physical state: Solid
- Storage condition of test material: Stable at room temperature
Specific details on test material used for the study:
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature

Test animals

Species:
rat
Strain:
other: Tif: RAIf (SPF)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Bred and raised on the premises
- Age at study initiation:
- Weight at study initiation: 197 - 252 g
- Fasting period before study:
- Housing: 10 animals per cage in Macrolon cages, Type 4 (Ehret, 783 Emmendingen/Germany)
- Diet (e.g. ad libitum): Ad libitum (NAFAG, Gossau/SG, Switzerland)
- Water (e.g. ad libitum): Ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 55 ± 10
- Photoperiod (hrs dark / hrs light): 14/10

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose only
Vehicle:
other: unchanged (no vehicle)
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Plexiglass exposure chamber
- Exposure chamber volume: 100 L
- Method of holding animals in test chamber: The rats were placed in separate PVC-tubes such that the snout and nostrils of the animals only
were exposed to the aerosol
- Source and rate of air: Air stream discharged into the exposure chamber at a rate of 10 L/min
- Method of conditioning air: Injection into an air stream
- System of generating particulates/aerosols: By introducing the solid test material with the aid of a Grafix Exaktomat Injector (Cerutti AG, Bern, Switzerland) into an air stream
- Method of particle size determination: 4 stage Cascade Impactor (C.F. Casella and Co., Ltd., Regent House, Britannia Walk, London) with Selectron filters (Schleicher and Schull AG, Feldbach, Switzerland) of 25 mm diameter and a pore size of 0.2 μm at an air flow rate of 17.5 L/min
-Pressure in air chamber: negative
Analytical verification of test atmosphere concentrations:
yes
Remarks:
gravimetrically by sampling the test atmosphere through a Selectron filter of 50 mm diameter and a 0.2 μm pore size
Duration of exposure:
4 h
Concentrations:
762 ± 41 and 1951 ± 68 mg/m3 (measured)
No. of animals per sex per dose:
10
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 1, 2 and 4 h as well as at 2 hours post-exposure and daily. Body weights were recorded immediately prior
to exposure and at day 7 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross examination

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LC50
Effect level:
> 1 951 mg/m³ air (analytical)
Exp. duration:
4 h
Sex:
male/female
Dose descriptor:
LC0
Effect level:
>= 1 951 mg/m³ air (analytical)
Exp. duration:
4 h
Mortality:
None
Clinical signs:
other: AlI animals exposed to the test material recovered within 6 days. Slight dyspnoea and ruffled fur were noted in both treatment groups
Body weight:
not affected
Gross pathology:
No gross pathological changes were observed.
Other findings:
The particle size distribution analysis of the chamber airborne particles showed that at least 82 % were smaller than 7 µm in diameter for all exposures.

Any other information on results incl. tables

TABLE 2. PHARMACOTOXIC SIGNS

Exposure level (mg/m3) Pharmacotoxic sign Observation period
Hours Day
Exposure
1 2 4 24 2 3 4 5 6 7 8 9 10 11 12 13 14
762 ± 41 Exophthalmus

+
+ +










Ruffled fur

+
+ + +









1951 ± 68 Exophthalmus

+
+ + +









Ruffled fur

+
+ + + +








Mild = +; Moderate = ++; Severe = +++

TABLE 3. MEAN BODY WEIGHT  ± SD (GRAMS)

Day Sex Concentration (mg/m3)
0 (control) 762 ± 41 1951 ± 68
1 Male 241 ± 9 252 ± 8 202 ± 12
Female 223 ± 6 224 ± 7 197 ± 9
7 Male 291 ± 8 286 ± 13 258 ± 13
Female 232 ± 9 231 ± 7 211 ± 9
14 Male 332 ± 13 330 ± 17 300 ± 15
Female 254 ± 10 250 ± 6 227 ± 10

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met